SIRT3 and lymphoma: Although NAD+ supplementation in A-T models is helpful in overcoming A-T neuropathology by improving NAD+/SIRT1 axis16,55, we suspect NAD+ will fuel tumor proliferation in A-T lymphoma cases associated with increased SIRT3 expression.